Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00054444 · ClinicalTrials.gov registry record · Phase 1
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
A Phase 1 study, sponsored by Gynecologic Oncology Group.
- Completed
- Registry status
- Phase 1
- Development phase
- 11
- Enrollment target
NCT00054444 is a Phase 1 study that has completed, run by Gynecologic Oncology Group. The registered enrollment target is 11 participants.
The verdict
NCT00054444, a Phase 1 study, has completed, sponsored by Gynecologic Oncology Group.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 11 participants
- Enrollment target
Study Summary
This phase I trial is studying the side effects and best way to give radiation therapy when given together with topotecan and cisplatin in treating patients with locally advanced cervical cancer. This trial is also studying the best dose of topotecan when given in this regimen. Radiation therapy uses high-energy x-rays to damage tumor cells. Drugs used in chemotherapy, such as topotecan and cisplatin, use different ways to stop tumor cells from dividing so they stop growing or die. Combining radiation therapy with chemotherapy may kill more tumor cells.
Interventions
- DRUG Cisplatin
- RADIATION 3-Dimensional Conformal Radiation Therapy
- DRUG Topotecan Hydrochloride Liposomes
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 11 participants |
| Start Date | 2007-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00054444
The ClinicalTrials.gov registry entry for NCT00054444 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 11 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Gynecologic Oncology Group, which has 154 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Cisplatin is the first listed.
NCT00054444 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00054444 about?
NCT00054444 is a clinical study titled "Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer". This phase I trial is studying the side effects and best way to give radiation therapy when given together with topotecan and cisplatin in treating patients with locally advanced cervical cancer. This trial is also studying the best dose of topotecan when given in this regimen. Radiation therapy use...
What is the current status of trial NCT00054444?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 11 participants. The study started on 2007-09.
What interventions are being tested in trial NCT00054444?
The interventions under investigation include: Cisplatin (DRUG), 3-Dimensional Conformal Radiation Therapy (RADIATION), Topotecan Hydrochloride Liposomes (DRUG).
Who is sponsoring clinical trial NCT00054444?
This trial is sponsored by Gynecologic Oncology Group, which has 154 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.